IL18 and cancer: The current findings, supported by the study of Yang et al. [38], show that the meta-analysis results indicate that the IL18 gene promoter − 607C >A polymorphism is significantly associated with an increased risk of cancer in general, particularly in cases of nasopharyngeal cancer and gastrointestinal cancer.